UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

The American journal of psychiatry, 2008-08, Vol.165 (8), p.1033-1039

2008

Volltextzugriff (PDF)

The Discovery of Fluoxetine Hydrochloride (Prozac)

Nature reviews. Drug discovery, 2005-09, Vol.4 (9), p.764-774

2005

Volltextzugriff (PDF)

A Novel Augmentation Strategy for Treating Resistant Major Depression

The American journal of psychiatry, 2001-01, Vol.158 (1), p.131-134

2001

Volltextzugriff (PDF)

Case history: the discovery of fluoxetine hydrochloride (Prozac)

Nature reviews. Drug discovery, 2005-09, Vol.4 (9), p.764-774

2005

Volltextzugriff (PDF)

Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study

Neuropsychopharmacology, 2003-09, Vol.28 (9), p.1685-1693

2003

Volltextzugriff (PDF)

Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder

Journal of experimental pharmacology, 2024, Vol.16, p.13-24

2024

Volltextzugriff (PDF)

Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

European journal of pharmacology, 2001-11, Vol.430 (2-3), p.341-349

2001

Volltextzugriff (PDF)

Biopharmaceutical Characterization, Metabolism, and Brain Penetration of the Triple Reuptake Inhibitor Amitifadine

Drug metabolism letters, 2013-03, Vol.7 (1), p.23-33

2013

Volltextzugriff (PDF)

Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice

Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (24), p.14096-14101

2001

Volltextzugriff (PDF)

Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles

Circulation (New York, N.Y.), 2004-06, Vol.109 (25), p.3202-3207

2004

Volltextzugriff (PDF)

Amantadine for weight gain associated with olanzapine treatment

European neuropsychopharmacology, 2005, Vol.15 (1), p.13-21

2005

Volltextzugriff (PDF)

Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice

Schizophrenia research, 2000-05, Vol.42 (3), p.249-259

2000

Volltextzugriff (PDF)

The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

European journal of pharmacology, 2001-08, Vol.426 (3), p.R3-R4

2001

Volltextzugriff (PDF)

Treatment of glossodynia with olanzapine

Journal of the American Academy of Dermatology, 2004-09, Vol.51 (3), p.463-465

2004

Volltextzugriff (PDF)

M 4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies

The FASEB journal, 2004-09, Vol.18 (12), p.1410-1412

2004

Volltextzugriff (PDF)

Cholinergic dilation of cerebral blood vessels is abolished in M 5 muscarinic acetylcholine receptor knockout mice

Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (24), p.14096-14101

2001

Volltextzugriff (PDF)

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

Psychopharmacologia, 1998-03, Vol.136 (2), p.153-161

1998

Volltextzugriff (PDF)

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α1-adrenergic receptors in vitro

Schizophrenia research, 1999-05, Vol.37 (1), p.107-122

1999

Volltextzugriff (PDF)

Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities: A Double-blind, Randomized, Placebo-Controlled Trial

Archives of general psychiatry, 2000-10, Vol.57 (10), p.968

Street, Jamie S.

2000

Volltextzugriff (PDF)

Conformationally Constrained Analogues of the Muscarinic Agonist 3-(4-(Methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine. Synthesis, Receptor Affinity, and Antinociceptive Activity

Journal of medicinal chemistry, 1998-01, Vol.41 (1), p.109-116

1998

Volltextzugriff (PDF)

Xanomeline, an M 1/M 4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice

Schizophrenia research, 2000-05, Vol.42 (3), p.249-259

2000

Volltextzugriff (PDF)

The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone

Primary care companion for CNS disorders, 2000-08, Vol.2 (4)

2000

Volltextzugriff (PDF)

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats

Psychopharmacology, 1996-03, Vol.124 (1-2), p.87-94

1996

Volltextzugriff (PDF)

Generation and pharmacological analysis of M 2 and M 4 muscarinic receptor knockout mice

Life sciences (1973), 2001-04, Vol.68 (22), p.2457-2466

2001

Volltextzugriff (PDF)

Investigations into the physiological role of muscarinic M 2 and M 4 muscarinic and M 4 receptor subtypes using receptor knockout mice

Life sciences (1973), 2001-04, Vol.68 (22), p.2473-2479

2001

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(63)
Buchkapitel
(1)

Sprache

Englisch
(64)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(24)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(15)
Neuropharmacology
(14)
Pharmacology & Pharmacy
(14)
Humans
(10)
Psychology. Psychoanalysis. Psychiatry
(9)
Psychopharmacology
(9)
Olanzapine
(7)
Schizophrenia
(7)
Male
(6)
Microdialysis
(6)
Psychiatry
(6)
Psycholeptics: Tranquillizer, Neuroleptic
(6)
Chemistry, Medicinal
(5)
Double-Blind Method
(5)
Neurosciences & Neurology
(5)
Norepinephrine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

The Discovery of Fluoxetine Hydrochloride (Prozac)

A Novel Augmentation Strategy for Treating Resistant Major Depression

Case history: the discovery of fluoxetine hydrochloride (Prozac)

Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study

Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder

Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

Biopharmaceutical Characterization, Metabolism, and Brain Penetration of the Triple Reuptake Inhibitor Amitifadine

Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice

Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles

Amantadine for weight gain associated with olanzapine treatment

Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice

The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

Treatment of glossodynia with olanzapine

M 4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies

Cholinergic dilation of cerebral blood vessels is abolished in M 5 muscarinic acetylcholine receptor knockout mice

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α1-adrenergic receptors in vitro

Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities: A Double-blind, Randomized, Placebo-Controlled Trial

Conformationally Constrained Analogues of the Muscarinic Agonist 3-(4-(Methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine. Synthesis, Receptor Affinity, and Antinociceptive Activity

Xanomeline, an M 1/M 4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice

The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats

Generation and pharmacological analysis of M 2 and M 4 muscarinic receptor knockout mice

Investigations into the physiological role of muscarinic M 2 and M 4 muscarinic and M 4 receptor subtypes using receptor knockout mice

Aktive Filter

Suchergebnisse filtern